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Abstract
Background: Single blastocyst transfer has the advantage of maximizing the fresh single pregnancy rate. However,
in patients with a low number of good quality embryos on day 3, it remains unclear whether immediate embryo
transfer or further embryo culture with blastocyst transfer is the most preferable option.
Methods: A retrospective cohort study was carried out in which the outcome of 590 fresh in vitro fertilization (IVF)
cycles over a 15 months period and their cryo cycles were analyzed. A total of 341 patients cycles had an elective
day 5 strategy independent of intermediate embryo evaluation while another 249 patients underwent a day 5
embryo transfer only if at least four embryos were available on day 3. Blastocyst vitrification was performed using a
closed high security system.
Results: Demographics, stimulation parameters and embryological data were comparable in the two groups.
Patients in the elective day 5 group had a lower fresh transfer rate (90.62% vs. 95.18%, p < 0.05) as compared to
patients with a day 3 or day 5 embryo transfer policy. No difference was observed in the fresh live birth rate and
multiple pregnancy rate per initiated cycle (32.84% vs. 28.92%; 1.17% vs 0%) The projected cumulative ongoing
pregnancy rate compensating for double counting in case subjects have more than one pregnancy is not different
(42.58% vs. 39.84%).
Conclusions: Despite lower fresh transfer rates, elective single blastocyst transfer yields a similar projected
cumulative ongoing pregnancy rate as in a policy with cleavage stage or blastocyst transfer depending on a good
quality embryo count on day 3.
Background
Single embryo transfer (SET) has been advocated as a
strategy to reduce the frequency of multiple births after
in vitro fertilization [1]. It has been established that the
significantly lower pregnancy rate achieved after single
cleavage stage embryo transfer as compared to a double
embryo transfer can be compensated by pregnancies
resulting from the first thawed cycle [2]. This finding
underscores the important role of cryopreservation in
enhancing the total reproductive potential of a single
cycle [3]. The introduction of the vitrification technique
as an efficient cryopreservation technique promises to
further increase the impact of cryo-technology on the
cycle specific pregnancy rates.
Fresh pregnancy rates can be optimized by performing
blastocyst transfer as such approach yields higher live
birth rates than single cleavage stage embryo transfer [4,5].
However, a systematic blastocyst transfer policy holds the
risk of cancelled embryo transfers, as extended embryo
culture may be unsuccessful. Morphological scoring of
embryo quality on day 3 may therefore offer a tool to iden-
tify patients that would potentially benefit from further
embryo culture [6]. The threshold of four good embryos
on the third day appeared to be a reassuring indication
that the patient will undergo an embryo transfer [6].
The aim of present study is to compare two approaches,
both aimed at a single blastocyst transfer. The outcome
after elective blastocyst transfer was compared with the
outcome of a blastocyst transfer or a cleavage stage transfer
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depending on whether the criteria of four good embryos on
the third day were met. Moreover, the additional cryo-
pregnancies and projected cryo-pregnancies through blas-
tocyst vitrification have been evaluated.
There is an ongoing debate on the microbiological
safety of cryopreservation since the report of a hepatitis
B transmission from contaminated cryopreserved bone
marrow and reports on potential contamination of
reproductive cells in experimental conditions [7,8].
Although no clinical reports of contamination have been
reported for reproductive cells and tissues, research is
ongoing aimed at eliminating such risks. In this study
we evaluate the effectiveness of blastocyst vitrification
performed with a high security vitrification system pre-
venting all contamination risk during vitrification and
storage.
Methods
Study design
A retrospective cohort study was performed. All fresh
IVF or ICSI treatment cycles were performed in a
15 months period from March 2008 until June 2009. All
cycles where the physicians’ initial treatment plan envi-
saged eSET with either a fixed day 5 transfer or with a
day 3 or day 5 transfer depending on the embryo quality
on day 3 were included. Only the first treatment cycle
was considered in case patients were undergoing multi-
ple attempts.
Embryo culture, evaluation and selection day of transfer
Sperm preparation, IVF/ICSI procedures and embryo
culture were carried out as described by Van Landuyt et
al. [9]. Oocytes and embryos were cultured in sequential
media and cultured at 37°C in an atmosphere of 6%
CO2, 5% O2 and 89% N2. Fertilization was assessed 16-
19 h after insemination or injection. On the morning of
day 3 embryos were transferred from cleavage medium
to blastocyst medium. Embryo quality was assessed daily
was scored as described by Papanikolaou et al., [6]
according to the following parameters: number of blas-
tomeres, rate of fragmentation, multinucleation of the
blastomeres and early compaction. Blastocyst quality on
day 5/6 was assessed according to the criteria of Gard-
ner and Schoolcraft [10].
Embryo cryopreservation procedures
For patients receiving transfer on day 3, supernumerary
cleavage stage embryos were cryopreserved and thawed
using standard slow freezing as described by Van den
Abbeel et al., (2005). Blastocyst vitrification was performed
using closed CBS-VIT High Security (HS) straws (Cryo
Bio system) in combination with DMSO-EG-S as the cryo-
protectants (Irvine ScientificR Freeze Kit). The vitrification
procedure was carried out at room temperature (between
22 and 27°C). Blastocysts were vitrified one by one. The
blastocyst was first incubated for 2 min in a 50 μl droplet
of HEPES-buffered culture medium. Then, the blastocyst
was brought in a 50 μl droplet of equilibration solution
(ES) containing 7.5% (v/v) DMSO and 7.5% (v/v) ethylene
glycol and incubated for 10 min. The blastocyst was then
transferred consecutively into four 25-μl droplets with
vitrification solution (VS) containing 15% (v/v) DMSO
and 15% (v/v) ethylene glycol. The blastocyst was incu-
bated for 5 sec in droplet 1 and 2 and for 10 sec in the 3rd
droplet. The blastocyst was then transferred to the fourth
droplet and immediately loaded onto the CBS-HS straw.
The straw was heat sealed and plunged into liquid nitro-
gen. The total time needed to vitrify the blastocyst starting
from VS droplet 1 to the loading of the straw and plun-
ging into liquid nitrogen did not exceed 90 sec.
On the day of transfer blastocysts were warmed one
by one until one blastocyst was available for transfer.
Blastocysts were warmed randomly, independent of the
blastocyst stage or ICM/TE quality prior to vitrification.
For warming, the Irvine ScientificR Thaw Kit was used. A
Petri-dish containing two 25 μl droplets with thawing
solution (TS, 1 M sucrose in Hepes buffered HTF med-
ium supplemented with 20% DSS) was kept at 37°C. For
warming the straw, the straw was transferred from the
LN2 storage container to a transport dewar filled with
liquid nitrogen. After cutting the straw and pulling the
capillary from the straw, the gutter was placed in the first
droplet with TS and the blastocyst was released from the
gutter and kept at room temperature. The blastocyst was
incubated for two times 1 min at room temperature in
the two TS droplets. The blastocyst was then transferred
to the first of two dilution solution droplets of 25 μl (DS;
0.5 M sucrose in Hepes buffered HTF medium supple-
mented with 20% DSS) and after that incubated for
2 min in a second DS droplet. Finally, the blastocyst was
washed in 3 droplets (25 μl) of washing solution (Hepes
buffered HTF medium supplemented with 20% DSS),
each for 3 min. The blastocyst was transferred to a cul-
ture dish with blastocyst medium to assess its morpholo-
gical survival. If the blastocyst was severely or completely
damaged, a new one was warmed immediately. If the
blastocyst was fully intact or showed moderate damage,
expansion and re-expansion was assessed 1-2 hours later.
If the morphological quality of the blastocyst was regres-
sing or no signs of re-expansion were present, a second
blastocyst was warmed until one blastocyst was suitable
for transfer i.e. with at least moderate survival and expan-
sion/re-expansion of the blastocyst
Statistical analysis
All data management and statistical analysis were per-
formed using the Statistical Package for the Social
Sciences version 17.0 (SPSS Inc. Chicago, OL, USA).
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Student’t t-test were performed on continuous variables
to determine differences in mean scores and standard
deviation (SD). Categorical variables were analyzed
using Chi square analysis. A significant level of 0.05 was
accepted throughout.
Results
Patient demographics and stimulation characteristics
(Table 1)
Overall 590 treatment cycles have been performed dur-
ing the observation period with 341 (58%) in the fixed
day 5 group and 247 (42%) in the day 3 or day 5 group.
The two groups were comparable with regard to age,
rank of trial, duration of stimulation and the total dose
of gonadotrophins administered.
Fresh embryo transfer: embryology data (Table 2)
Overall, no differences were observed in the total number
of cumulus-oocyte complexes, MII oocytes or 2PN
oocytes. However, a significantly lower number of cumu-
lus-oocyte complexes, MII oocytes and 2PN oocytes were
available in the subgroup of patients with a transfer on
day 3. Patients with the fixed day 5 approach had a lower
subjects’ fresh transfer rate (90.62% vs. 95.18%, p < 0.05)
but the embryo fresh transfer rate and the embryo cryo-
preservation rate was similar. For patients in the day 3 or
day 5 group, a higher embryo fresh transfer rate and a
lower embryo cryopreservation rate were observed in
patients with a transfer on day 3. The data reported sepa-
rately for the day 3 and day 5 subgroups only included
cycles with embryo transfer as cancelled cycles (n = 12)
cannot be allocated to either one of the two subgroups.
Fresh embryo transfer: outcome (Table 3)
No differences were observed in terms of clinical preg-
nancy rate, ongoing pregnancy rate or live birth rate
between the fixed day 5 and the day 3 or day 5 transfer
policies. These outcome parameters also did not differ
between the two subgroups within the day 3 or day 5
transfer policy. Multiple pregnancies were only observed
in the fixed day 5 approach (1.29%) but did not statisti-
cally higher than in the other transfer approach group.
Frozen embryo transfer: embryology data (Table 4)
An overall embryo transfer rate of 69.9% was observed
in the fixed blastocyst group which was not significantly
different from the overall embryo transfer rate of 65.5%
was observed for day 3 and day 5 embryos combined in
the other group. The embryo transfer rate was statisti-
cally higher in the day 5 subgroup as compared to the
day 3 subgroup (76.5% vs. 46.4%, p < 0.001). No differ-
ences were observed in the transfer specific or subject
specific clinical pregnancy rates.
Frozen embryo transfer: outcome (Table 5)
Single embryo transfer was performed in 83% of all fro-
zen blastocyst transfers in the fixed day 5 group. Single
blastocyst transfers in the day 5 subgroup of the day
3 or day 5 group counted for 85.6% of the cycles which
was significantly more than the 50% SET observed in
the day 3 subgroup. The ongoing pregnancy rate per
frozen embryo transfer in the fixed day 5 groups was
14.04%, which was not different from the overall
ongoing pregnancy rate of the day 3 or day 5 group
(14.63%). Multiple pregnancy rates were not different
between the different approaches.
Summary and projected outcome (Table 6)
The clinical and ongoing pregnancy rate per thawed
embryo was not different between the two groups.
Neither was the projected cumulative clinical and
ongoing pregnancy rate different between the elective
day 5 group (44.12%; 42.58%) versus the day 3 or day 5
group (44.04%; 39.84%).
Discussion
This study has shown that a single blastocyst transfer
policy can be decided before the initiation of the in
Table 1 Patient demographics and stimulation characteristics
eSET with elective day 5 transfer eSET with transfer day 3 or 5 Statistical significance
No. subjects 341 249 -
Age (years) 29.94 (3.54) 31.20 (3.18) NS
Rank of trial 0.29 (0.61) 0.39 (0.68) NS
Days of stimulation 9.53 (2.09) 9.83 (2.22) NS
Total gonadotropin dose (IU) 1745.95 (632.93) 1857.56 (685.55) NS
Day 3 Day 5
No. subjects 135 102
Age (years) 31.24 (3.23) 31.30 (3.11) NS
Rank of trial 0.36 (0.66) 0.44 (0.73) NS
Days of stimulation 9.94 (2.35) 9.78 (1.98)
Total gonadotropin dose ((IU) 1907.56 (671.37) 1800.17 (704.74) NS
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vitro fertilization (IVF) cycle. A day 3 or day 5 embryo
transfer policy based on day 3 embryo evaluation does
not increase cycle outcome. It merely divides the patient
population based on their ovarian response and reduces
the risks of a cancelled embryo transfer.
Randomized controlled trials have shown that a blas-
tocyst transfer policy results in a significantly higher live
birth rate [5,11] However, the effect of a fresh blastocyst
transfer policy on the cumulative pregnancy rate, includ-
ing cryo-cycles has not been evaluated in these trials.
A recent prospective trial by Guerif et al., [12] did
include embryo cryopreservation by slow freezing techni-
que when comparing a single day 2 with a single blastocyst
transfer policy. Although blastocyst transfer yielded a
higher live birth rate in the fresh cycles, it appeared to
result in the same cumulative pregnancy rate after adding
cryo-cycles. The authors concluded that improvements in
blastocyst cryopreservation were needed in order to claim
superiority of the blastocyst transfer policy. The imple-
mentation of the vitrification technique may provide such
Table 2 Embryology data: fresh embryo transfer
eSET with elective day 5
transfer
eSET with transfer day 3 or 5 Statistical
significance
Proportion IVF/ICSI as in vitro fertilization procedure
(%)
IVF 44/341 (12.90) 24/247 (9.72) NS
ICSI 297/341 (87.10) 223/247 (90.28) NS
Mean No. cumulus-oocyte complexes (SD) 12.33 (7.23) 11.66 (7.35) NS
Mean No. metaphase II oocytes 8.50 (6.26) 8.27 (6.46) NS
Mean No. two pronuclei oocytes 7.46 (5.03) 7.11 (4.95) NS
Embryos on day 3 2393 16901 -
Embryos on day 5 1619 8162
Embryos transferred fresh 309 237 -
Embryo fresh transfer rate (%) 309/1619 (19.09) 237/13903 (17.05) NS
Subjects with fresh transfer 309 237 -
Subjects fresh transfer rate (%) 309/341 (90.62) 237/249 (95.18) <0.05
Embryos cryopreserved 640 5604 -
Embryo cryopreservation rate (%) 640/1619 (39.53) 5604/14651 (38.22) NS
Subjects with cryopreservation 191 1665 -
Subjects cryopreservation rate (%) 191/309 (61.81) 166/237 (70.04) 0.05
Day 3 Day 5
Proportion IVF/ICSI as in vitro fertilization procedure
(%)
IVF 12/135 (8.89) 10/102 (9.80) NS
ICSI 123/135
(91.11)
92/102 (90.20) NS
Mean No. cumulus-oocyte complexes (SD) 9.18 (5.92) 14.52 (6.25) <0.05
Mean No. metaphase II oocytes (SD) 6.00 (4.31) 11.01 (6.08) <0.05
Mean No. two pronuclei oocytes (SD) 4.73 (3.00) 10.05 (4.06) <0.05
Embryos on day 3 615 1000 -
Embryos on day 5 NA 775 -
Embryos transferred fresh 135 102 -
Embryo fresh transfer rate (%) 135/615
(21.95)
102/775
(13.16)
<0.001
Embryos cryopreserved 154 363
Embryo cryopreservation rate (%) 154/615
(25.04)
363/775
(46.84)
<0.001
Subjects with cryopreservation 80 84 -
Subjects cryopreservation rate (%) 80/135 (59.26) 84/102 (82.35) <0.001
1 including 75 day 3 embryos from 6 subjects without fresh transfer.
2 including 41 day 5 embryos from 2 subjects without fresh transfer.
3 available day 3 embryos for subjects with fresh day 3 transfer and available day 5 embryos for subjects with fresh day 5 transfer.
4 including 43 embryo cryopreserved on day 3 and 5 in subjects without fresh transfer.
5 including 2 subjects with cryopreserved embryos without fresh transfer.
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effect, however it would also further increase cleavage
stage cryopreservation outcome.
A meta analysis concludes that vitrification appears to
be associated with a significantly higher postthawing
survival rate than slow freezing [13]. The superiority of
vitrification is also illustrated by comparing vitrification
outcome in this study with previously published data on
blastocyst slow-freezing at the same centre [14]. A
reported embryo transfer rate ranging between 48.9%
and 52.2% after slow freezing [14] has been substantially
increased to rates varying between 69.9% and 76.5%
after vitrification.
Table 3 Fresh embryo transfer outcome
eSET with elective day 5 transfer eSET with transfer day 3 or 5 Statistical significance
/cycle /ET /cycle /ET /cycle
Pregnancy rate (positive hCG) 141/341 (41.35) 141/309 (45.63) 95/249 (38.15) 95/237 (40.08) 0.45
Clinical pregnancy rate 121/341 (35.48) 121/309 (39.16) 79/249 (31.73) 79/237 (33.30) 0.38
Ongoing pregnancy rate 118/341 (34.60) 118/309 (38.19) 73/249 (29.32) 73/237 (30.80) 0.18
Pregnancy loss
Miscarriage 14 14 10 10 -
Ectopic pregnancy 5 5 1 1 -
Live birth rate 112/341 (32.84) 112/309 (36.25) 72/249 (28.92) 72/237 (30.38) 0.32
Mulitple pregnancy rate 4/341 (1.17) 4/309 (1.29) 0/249 (0) 0/237 (0) 0.16
Day 3/cycle (%) Day 5/cycle (%)
Pregnancy rate (positive hCG) 47/135 (34.81) 48/102 (47.06) 0.08
Clinical pregnancy rate 39/135 (28.89) 40/102 (39.26) 0.10
Ongoing pregnancy rate 36/135 26.67) 37/102 (36.27) 0.16
Pregnancy loss
Miscarriage 6 4 -
Ectopic pregnancy 1 0 -
Live birth rate 36/135 (26.67) 36/102 (35.29) 0.16
Mulitple pregnancy rate 0/135 (0) 0/102 (0) 1
Table 4 Efficiency of cryopreservation and pregnancy potential of surviving embryos
eSET with elective day 5 transfer eSET with transfer day 3 or 5 Statistical significance
No. of embryos cryopreserved 640 517
No. of thawing cycles 188 143
No. of embryos thawed 286 229
No. of embryos surviving 200 150
Transferrable survival rate 200/286 (69.9) 150/229 (65.5) NS
Subjects with thawed transfers 109 71
Total number of thawed transfers 171 125
Total number of clinical pregnancies 26 21
Transfer specific pregnancy rate1 26/171 (15.2) 21/125 (16.8) NS
Subject specific pregnancy rate2 26/109 (23.9) 21/71 (29.6) NS
Day 3 Day 5
No. of embryos cryopreserved 154 363
No. of thawing cycles 41 102
No. of embryos thawed 84 145
No. of embryos surviving 39 111
Transferrable survival rate 39/84 (46.4) 111/145 (76.5) <0.001
Subjects with thawed transfers 26 45
Total number of thawed transfers 28 97
Total number of clinical pregnancies 4 17
Transfer specific pregnancy rate1 4/28 (14.3) 17/97 (17.5) NS
Subject specific pregnancy rate2 4/26 (15.4) 17/45 (37.8) 0.05
1 Total number of pregnancies/total number of thawed transfers.
2 Total number of pregnancies/number of subjects with thawed transfers.
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The question whether cumulative pregnancy chances
are affected by a cleavage stage embryo transfer versus
blastocyst culture and blastocyst transfer based on a day
3 embryo quality evaluation remained unanswered. This
study showed that such a embryology based policy
mainly divides the patient population based on their
ovarian response. The inherent reduced reproductive
potential is illustrated by the low transferrable embryo
survival rate of 46.4% compared to 65.1% as previously
published in elective day 3 population in the same cen-
tre [15]. An alternative interpretation of the dataset is
that a day 5 transfer is not required for a large propor-
tion of the patients as the day 3/day 5 subgroups com-
parison for pregnancy rates are comparable.
In this study we used an aseptic method for the vitrifi-
cation of embryos. Although the transmission of infec-
tious diseases through cryopreservation and storage of
embryos has never been reported, such possibility exists
under experimental conditions [7,16]. Therefore, the
application of hermetically sealed containers or second-
ary enclosure (for cryovials and open vitrification sys-
tems) is suggested [16]. The hermetically sealed device
used in this study has the advantage that both vitrifica-
tion and storage are perfomed under ‘closed’ conditions.
Aseptical vitrification using open devices would require
sterilization of liquid nitrogen and a secondary enclosure
for storage [17].
For the vast majority of patients, the single embryo
transfer policy was based on the Belgian law imposing a
SET policy in women less than 36 years [18]. No strict
SET policy was applied in the thawed embryo transfer
cycles, with significantly more DET (double embryo
transfer) in the frozen day 3 embryo transfers. The higher
proportion of DET in the frozen day 3 cycles (50%) as
compared to the frozen blastocyst cycles (14.6%) can be
explained by a lower expected implantation rate and
resulted in a similar ongoing pregnancy rate per transfer
(15.38% vs. 14.43%). The p value for the subject specific
clinical pregnancy rate comparing the day 3 and day 5
embryo transfer reaches 0.05, although no difference has
been observed in the pregnancy rate per transfer. The
high subject specific pregnancy rate in the day 5 group
appears to be due to the significantly higher transferrable
survival rate and the embryo transfers performed.
Although no differences were observed in patients’
and treatment characteristics, the retrospective design
remains a weakness. The allocation of patients to one or
the other group is based on the view of the individual
Table 5 Frozen embryo transfer outcome
eSET with elective day 5
transfer
eSET with transfer day 3 or 5 Statistical
significance
/cycle (n =
188)
/ET (n = 171) /cycle (n = 143) /ET (n = 123)
Positive hCG (%) 34/188 (18.06) 34/171
(19.88)
30/143 (21.00) 30/123 (24.39) NS
Clinical pregnancy rate (%) 26/188 (13.83) 26/171
(15.20)
21/143 (14.69) 21/123 (17.07) NS
Ongoing pregnancy rate
(%)
24/188 (12.77) 24/171
(14.04)
18/143 (12.56) 18/123 (14.63) NS
Pregnancy loss
Miscarriage 2/26 (7.69) 3/20 (20) NS
Ectopic pregnancy 0 1/30 (3.33) NS
Single embryo transfer (%) 142/171 (83.0) 96/123 (78.05) NS
Multiple pregnancy rate (%) 2/24 (8.33) 1/18 (5.56) NS
Day 3 Day 5
/cycle (n =
41)
/ET (n = 26) /cycle (n =
102)
/ET (n = 97)
Positive hCG (%) 5/41 (12.20) 5/26 (19.23) 25/102 (24.51) 25/97
(25.77)
NS
Clinical pregnancy rate (%) 4/41 (9.76) 4/26 (15.38) 17/102 (16.67) 17/97
(17.53)
NS
Ongoing pregnancy rate
(%)
4/41 (9.76) 4/26 (15.38) 14/102 (13.72) 14/97
(14.43)
NS
Pregnancy loss
Miscarriage 0 3/17 (17.6) NS
Ectopic pregnancy 0 1/25 (4) NS
Single embryo transfer (%) 13/26 (50.0) 83/97 (85.6) <0.001
Multiple pregnancy rate (%) ¼ (25) 0 NS
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physician in the centre and the preferences of the
patient. Establishing a prospective randomized con-
trolled trial will generate anxiety amongst patients and
clinicians. This retrospective data will be reassuring for
centers wishing to investigate this subject further.
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